title: Absence of transplacental passage of fragmin (Kabi) during the second and the third trimesters of pregnancy.
authors.forename: F
authors.initials: F
authors.lastname: Forestier
authors.forename: Y
authors.initials: Y
authors.lastname: Solé
authors.forename: M
authors.initials: M
authors.lastname: Aiach
authors.forename: M
authors.initials: M
authors.lastname: Alhenc Gélas
authors.forename: F
authors.initials: F
authors.lastname: Daffos
mesh_terms: D001777:Blood Coagulation / Q000187:drug effects; D005260:Female; D005312:Fetal Blood / Q000187:drug effects; D005865:Gestational Age; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000493:pharmacokinetics*; D006801:Humans; D008431:Maternal-Fetal Exchange; D010920:Placenta / Q000378:metabolism*; D011247:Pregnancy
chemical_list: D006495:Heparin, Low-Molecular-Weight